Loading stock data…
Universe Pharmaceuticals INC (UPC)
$12.18+9.22 (+311.49%)
Market ClosedLast close Jun 29
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Universe Pharmaceuticals INC in the Healthcare sector is trading at $12.18 with a market capitalization of $2M. The stock is currently 32% below its 52-week high of $17.96, remaining 227.4% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q3 2025 | Q1 2025 | Q3 2024 | Q1 2024 | Q3 2023 |
|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| Net Income | — | — | — | — | — |
Peer Comparison
JNJUNHPFE
Fundamentals
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.96M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-
Volume
Today's trading volume
54.52M
Recent News
UPC Stock Surges 288% After Hours — What’s Driving The Rally?
Universe Pharmaceuticals agreed to buy 100% of Best Praise International Limited, a company that holds five patents in China.
Universe Pharmaceuticals Reports First Half 2025 Earnings
Universe Pharmaceuticals ( NASDAQ:UPC ) First Half 2025 Results Key Financial Results Revenue: US$9.15m (down 29% from...